Name | Price | Price Change | Analyst Price Target | Market Cap | Yearly Gain | Analyst Consensus | Smart Score | Follow |
---|---|---|---|---|---|---|---|---|
Pfizer | $48.13 | $57.64 (19.76% Upside) | $274.37B | 1.14% | 4 Buy 7 Hold 0 Sell Moderate Buy | premium | ||
Moderna | $141.81 | $217.89 (53.65% Upside) | $55.73B | -65.41% | 4 Buy 5 Hold 1 Sell Moderate Buy | premium | ||
BioNTech SE | $149.15 | $211.00 (41.47% Upside) | $35.99B | -60.81% | 4 Buy 6 Hold 0 Sell Moderate Buy | premium | ||
Johnson & Johnson | $166.53 | $187.60 (12.65% Upside) | $440.62B | -3.16% | 7 Buy 4 Hold 0 Sell Moderate Buy | premium | ||
AstraZeneca | $66.72 | $77.50 (16.16% Upside) | $208.71B | 17.02% | 2 Buy 0 Hold 0 Sell Moderate Buy | premium | ||
Novavax | $35.78 | $97.40 (172.22% Upside) | $2.77B | -85.87% | 7 Buy 0 Hold 1 Sell Strong Buy | premium | ||
Inovio Pharmaceuticals | $2.37 | $4.00 (68.78% Upside) | $576.12M | -71.53% | 1 Buy 2 Hold 0 Sell Moderate Buy | premium |